Valuation (12%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -5.59 | 46.83 |
PEG Ratio (TTM) | -0.06 | 0.69 |
P/S Ratio (TTM) | 7.49 | 18.39 |
P/B Ratio (TTM) | 5.50 | 15.82 |
P/FCF Ratio (TTM) | -0.93 | 40.42 |
Price to 5YR AVG Earnings Ratio | N/A | 72.22 |
Price to 5YR AVG FCF Ratio | N/A | 98.26 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -88.18% | -2.87% |
ROE (TTM) | -68.62% | 9.30% |
Net Profit Margin (TTM) | -1,874.60% | 4.22% |
ROIC 5YR AVG | N/A | 5.38% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 14.14% | N/A | N/A |
Revenue | -3.75% | N/A | N/A |
Net Income | 12.21% | N/A | N/A |
Cash Flow | -2.32% | N/A | N/A |
Health (47%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 11.08 | 1.87 |
Quick Ratio (TTM) | 11.08 | 1.86 |
D/E Ratio (TTM) | 0.01 | 0.52 |
Interest Coverage (TTM) | -0.57 | 12.71 |
Piotroski F-Score | 3 | 6 |
Altman Z-Score | 0.29 | 10.59 |
LTL to 5YR AVG FCF | N/A | 3.83 |
Shares Outstanding Growth 5YR AVG | N/A | 53.63% |